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Objectives: To characterize the microbiota present in the lungs of patients with
cystic ﬁbrosis (CF) and non-CF related bronchiectasis (BE), and to determine
changes in diversity and relative abundance during exacerbations and when patients
were clinically stable.
Methods: Sputum samples from CF (n = 48) and BE ( n=28) patients were
processed using culture dependent (strict anaerobic culture) and culture independent
(454-FLX) methods. Agreement between the two methods, microbial diversity
(Shannon-Wiener Index) and abundance within samples was determined.
Results: Correlation was apparent between the methods for quantitation of the main
bacterial genera such as Pseudomonas spp. (r = 0.46; P = 0.015) and Burkholderia
spp. (r = 0.79; P = 0.001) in CF, and Haemophilus spp. (r = 0.71; P < 0.001) and
Pseudomonas spp. (r = 0.80; P < 0.001) in BE. Although rich microbial communities
were observed within CF and BE airways, a small number of genera represented
approximately 90% of all sequences. Diversity in patients predominantly infected
with Pseudomonas spp. did not differ from diversity in the pooled samples
for either of the cohorts (CF, P = 0.28; BE, P = 0.33). However, diversity was
reduced in patient’s predominantly infected by Bukholderia spp. (CF, P < 0.001)
and Haemophilus spp. (BE, P = 0.0053).
Conclusions: There was a correlation between abundance of the predominant
organisms by both methods, with both required to construct a comprehensive picture
of the airway microbiota. Reduced microbial diversity was primarily related to the
presence of Burkholderia spp. and Haemophilus spp. in CF and BE, respectively.
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Objective: To determine whether the addition of acetamide nutrient broth (ANB) to
our standard solid media-based method increased the isolation rate of P. aeruginosa
from cough swabs.
Method: Between January 2011 and February 2011 323 cough swabs were exam-
ined using a standard solid media-based method. The tip of each cough swab was
subsequently placed into ANB, incubated for 24 hours at 37ºC, and sub-cultured
onto solid media. The additional ANB sub-cultures were examined in a blinded
fashion to the standard method cultures. All suspect isolates from either method
were ﬁrst provisionally identiﬁed using colonial appearance, oxidase reaction and
API 20NE. All isolates suspected to be P. aeruginosa were conﬁrmed by species-
speciﬁc PCR.
Results: Overall, 39 (12%) cough swabs were positive for P. aeruginosa by
either method. Only 23 were positive using the standard method whereas 35 were
positive following pre-incubation in ANB. The sensitivity of cough swab culture
for P. aeruginosa was higher following the use of ANB (90%) than by using solid
media alone (59%).
Conclusion: The addition of ANB increased the sensitivity of cough swab cultures
for the isolation of P. aeruginosa from people with CF.
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During the period of 2002 to 2011, 267 patients with CF were followed in our
outpatient clinic. In this period routine microbiological samples of the upper
respiratory tract (URT) were processed based on ASM Manual and Vitek I. In 2006
BCSA was introduced and LMG strains QC, and so, since 2010 Vitek II and PCR for
routine inconclusive non-fermentative (NFB) bacteria. Among the 267 patients, 72%
had at least one sample positive for Pseudomonas aeruginosa and 40% (108) had
more than three positive samples in one year, 82% of these being characterized as
chronic infections, 10% intermittent colonization and 8% of patients had eradication
after chronic status. Burkholderia cepacia complex was isolated in 65 patients
(prevalence 24%), with only 5 cases considered chronically infected (1.8%). For
Achromobacter spp., 50% of all patients had at least one positive sample in URT,
with only 6.6% (9 cases) with persistent colonization and only 3 patients maintain
positive cultures for over 5 years. Stenotrophomonas maltophilia was isolated in
26% but only for 5 cases were persistent for >3 years, associated with severe
pulmonary damage and other potential pathogens. Among other NFB that may be
related to pathogenicity, from 14 patients were isolated Chryseobacterium spp.,
6 Cupriavidus pauculus, 5 Alcaligenes spp., 5 Elizabethkingia meningosepticum,
4 Bordetella bronchiseptica, 4 Ochrobactrum antropii, 2 Ralstonia sp., 2 Delftia
acidovorans, 1 Burkholderia gladioli and 1 Rhizobium radiobacter. Improved
methods for identifying bacteria may clarify the pathogenic potential of these
NFB, but it is still clear the predominance of P. aeruginosa, B. cepacia complex,
Achromobacter spp. and S. maltophilia and its association with patients with poor
lung function.
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Background: Matrix-assisted laser desorption ionization time-of-ﬂight (MALDI-
TOF) mass spectrometry has emerged as a rapid and powerful tool for routine
identiﬁcation of bacteria in clinical microbiology. The objective of our study was
to identify exhaustively all bacterial isolates growing in standard agar plates from
sputum samples of Cystic Fibrosis (CF) patients.
Methodology/principal ﬁndings: From November to December 2011, we collected
80 sputum samples corresponding to 68 patients including 40 children and 28
adults in two CF medical center from Marseille, France. All samples were cultured
on 4 speciﬁc agar plates including CNA (columbia colistin-nalidixic acid), PVX
(chocolate PolyViteX agar), Mac Conkey agar, and Cepacia agar. All colonies
retrieved from these plates were identiﬁed using MALDI-TOF mass spectrometry.
Overall, 507 different colonies were collected (mean at 5.8 colonies per sample)
leading to the identiﬁcation of 58 different bacterial species. Many colonies not
correctly identiﬁed were in fact yeasts that represent about 20% of the total colonies.
Among the remaining isolates about 3 to 5% could not be identiﬁed even after
reisolation and correct identiﬁcation by PCR ampliﬁcation and sequencing is in
progress.
Conclusions: Since MALDI-TOF is a fast and reliable method for bacterial iden-
tiﬁcation, we believe that this technique associated with more extensive cultivation
approaches will enhance the number of new and/or emerging bacterial species
recovered from CF. This will help to understand the complexity and the dynamic of
this complex microbiota during exacerbations as well as during antibiotic treatment.
